LPTX - Leap Tx Short-Term Debt to Capital

The visual price action of Leap Therapeutics, Inc. (LPTX) on the GURU.Markets platform demonstrates the asset's dynamics, where the indicator stands at 0.05. Leap Therapeutics, Inc. (LPTX) is optimizing the creation of antibodies to combat gastrointestinal tumors by implementing AI solutions and robotics. The business relies on the high margins of drug synthesis and the global potential of its patents. The expansion of its partnership network with US clinics and FDA approval will secure the firm a dominant position in the industry.

This indicator measures the business's reliance on short-term borrowings relative to equity, allowing for an assessment of liquidity risks should the cost of credit resources change. By analyzing the share of short-term loans within the company's capital, an investor can identify a critical vulnerability for Leap Therapeutics, Inc. (LPTX), whose funding is limited to one-time partner payments amid a lack of stable revenue from clinical trials.